Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Afuresertib hydrochloride is an inhibitor of Akt kinase (Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively)
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 68.00 | |
10 mg | In stock | $ 96.00 | |
25 mg | In stock | $ 166.00 | |
50 mg | In stock | $ 266.00 | |
100 mg | In stock | $ 460.00 | |
200 mg | In stock | $ 598.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 78.00 |
Description | Afuresertib hydrochloride is an inhibitor of Akt kinase (Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively) |
Targets&IC50 | Akt3:2.6 nM(Ki), Akt2:2 nM(Ki), Akt1:0.08 nM(Ki) |
In vitro | Afuresertib-induced p21 expression promotes G1 phase arrest by inducing FOXO activity.?Furthermore, afuresertib significantly enhanced cisplatin-induced cytotoxicity.Afuresertib modulated the expression E2F1 and MYC, which are associated with fibroblast core serum response.?Suggest that afuresertib is a useful anticancer drug for treating patients with MPM[1]. |
Cell Research | Cell confluence proliferation assay was performed using Incucyte ZOOM Live‐Cell Imaging System.?Briefly, ACC‐MESO‐4 and MSTO‐211H cells were seeded in 12‐well plates (cell density, 1 × 104 cells/well) and were incubated for 24 h at 37°C.?Then, the cells were incubated with 0, 2, 5, or 10 μmol/L afuresertib.?During treatment, cell growth was monitored by recording phase images using the IncuCyte ZOOM Live‐Cell Imaging System (magnification, ×100)[1]. |
Molecular Weight | 463.8 |
Formula | C18H18Cl3FN4OS |
CAS No. | 1047645-82-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (215.62 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Afuresertib hydrochloride 1047645-82-8 Cell Cycle/Checkpoint Chromatin/Epigenetic Cytoskeletal Signaling PI3K/Akt/mTOR signaling Stem Cells PKC Akt ROCK Afuresertib Afuresertib Hydrochloride Protein kinase C PKB Rho-kinase GSK2110183 ROK Rho-associated protein kinase Inhibitor GSK-2110183 inhibit Protein kinase B Rho-associated kinase GSK 2110183 inhibitor